
The latest high-profile incident of a ransomware attack caused one of the biggest gas and fuel suppliers in the U.S. to close its East Coast pipeline for several days, a worrisome reminder that each industry remains vulnerable to cyberattacks. And not surprisingly, pharmaceutical companies also are easy targets, according to a new analysis.
To wit, nearly 10% of drug makers are “highly” susceptible to a ransomware attack and 43% of the industry’s data management vendors are likely to incur such an attack. And almost half of 200 drug companies have more than 1,000 employees whose user names and passwords were exposed on the deep web in the last 90 days, according to Black Kite, a cybersecurity consulting firm.
To quote the not-so-old saw – “It’s not a question of IF, but WHEN.”